Man Group’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,193
Closed -$285K 2150
2022
Q3
$285K Buy
+1,193
New +$319K ﹤0.01% 1681
2022
Q2
Sell
-1,485
Closed -$639K 1419
2022
Q1
$1.01M Buy
1,485
+466
+46% +$280K ﹤0.01% 1371
2021
Q4
$704K Sell
1,019
-125
-11% -$92.4K ﹤0.01% 1429
2021
Q3
$848K Buy
1,144
+67
+6% +$45.7K ﹤0.01% 1380
2021
Q2
$807K Buy
1,077
+476
+79% +$364K ﹤0.01% 1431
2021
Q1
$490K Buy
+601
New +$464K ﹤0.01% 1482

Other funds holding OM

Man Group's OM Position: Q4 2022 in Review

Man Group sold out of Outset Medical (OM) in Q4 2022, closing a stake of 1,193 shares — an estimated $285K sold.

Man Group first reported a position in OM in Q1 2021 and held it in 6 quarters. The position peaked at $1.01M in Q1 2022. 152 funds tracked by Wall St. Rank hold OM as of Q4 2022.

  • Man Group reported no remaining Outset Medical position as of Q4 2022 after selling out during the quarter.
  • Man Group sold 1,193 Outset Medical shares in Q4 2022, an estimated $285K.
  • Man Group first reported a position in Outset Medical in Q1 2021 and held it in 6 quarters.
  • Man Group's Outset Medical position peaked at $1.01M in Q1 2022.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.